Kura Oncology Logo
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
November 02, 2023 07:30 ET | Kura Oncology, Inc.
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Final Logo-01.png
[Latest Report] Clinical Communication and Collaboration Market is estimated to be US$ 5.1 billion by 2032; Growing adoption of Digital Technologies to Fuel Market Growth-By PMI
September 05, 2023 15:30 ET | PMI
Covina, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Technological advancement has become major factor in market growth. Further, rising use of smart devices in hospitals has driven target market growth as...
Reports and Data.jpeg-01
Clinical Communication and Collaboration Market Size to Reach USD 5,029.8 Million By 2027 | Increasing Use of Connected Devices in Hospitals will be the Key Factor Driving the Industry Growth, States Reports and Data
January 29, 2021 07:11 ET | Reports and Data
New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- The global clinical communication and collaboration market is expected to reach a market size of USD 5,029.8 Million by 2027 and register a significantly...
FINAL lOGO.png
Global Clinical Communication and Collaboration Market to reach US$ 861.6 Mn by 2025 - Persistence Market Research
October 25, 2017 07:01 ET | Persistence Market Research
New York, Oct. 25, 2017 (GLOBE NEWSWIRE) -- According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry...
Connecticut Childrens Medical Center logo
Connecticut Children's Medical Center and Harvard Apparatus Regenerative Technology Collaborate to Develop Bioengineered Pediatric Esophageal Solutions
August 10, 2015 10:46 ET | Connecticut Childrens Medical Center
HARTFORD, Conn., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Connecticut Children's Medical Center has entered into an agreement with Harvard Apparatus Regenerative Technology, Inc., (NASDAQ: HART), or HART, a...